ENTA
Enanta Pharmaceuticals Inc
Price:  
13.46 
USD
Volume:  
192,059.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA EV/EBITDA

-789.8%
Upside

As of 2024-02-26, the EV/EBITDA ratio of Enanta Pharmaceuticals Inc (ENTA) is -1.76. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ENTA's latest enterprise value is 246.30 mil USD. ENTA's TTM EBITDA according to its financial statements is -139.59 mil USD. Dividing these 2 quantities gives us the above ENTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.8x - 13.7x 11.8x
Forward P/E multiples 13.9x - 17.7x 16.9x
Fair Price (89.62) - (88.69) (92.85)
Upside -765.8% - -758.9% -789.8%
13.46 USD
Stock Price
(92.85) USD
Fair Price

ENTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-23 -2.06
2024-02-22 -1.91
2024-02-21 -1.99
2024-02-20 -1.96
2024-02-16 -1.99
2024-02-15 -2.03
2024-02-14 -2.02
2024-02-13 -1.88
2024-02-12 -1.89
2024-02-09 -1.89
2024-02-08 -1.89
2024-02-07 -1.88
2024-02-06 -1.92
2024-02-05 -1.89
2024-02-02 -1.88
2024-02-01 -1.96
2024-01-31 -1.86
2024-01-30 -1.87
2024-01-29 -1.92
2024-01-26 -1.87
2024-01-25 -1.88
2024-01-24 -1.85
2024-01-23 -1.87
2024-01-22 -1.80
2024-01-19 -1.79
2024-01-18 -1.78
2024-01-17 -1.82
2024-01-16 -1.72
2024-01-12 -1.72
2024-01-11 -1.73
2024-01-10 -1.83
2024-01-09 -1.82
2024-01-08 -1.90
2024-01-05 -1.85
2024-01-04 -1.84
2024-01-03 -1.62
2024-01-02 -1.54
2023-12-29 -1.44
2023-12-28 -1.49
2023-12-27 -1.48
2023-12-26 -1.45
2023-12-22 -1.40
2023-12-21 -1.36
2023-12-20 -1.30
2023-12-19 -1.41
2023-12-18 -1.37
2023-12-15 -1.43
2023-12-14 -1.48
2023-12-13 -1.48
2023-12-12 -1.38